Drug Discovery & Development - January 20, 2011
PITTSBURGH (AP) — Drug developer Mylan Inc. said that the Food and Drug Administration tentatively approved the company's pediatric HIV treatment.
The company said the Lamivudine and Zidovudine tablets will be eligible for purchase outside the U.S. in certain developing countries.
Date: January 20, 2011
Source: Associated Press
The company said the Lamivudine and Zidovudine tablets will be eligible for purchase outside the U.S. in certain developing countries.
Date: January 20, 2011
Source: Associated Press
No hay comentarios:
Publicar un comentario